Erschienen in:
25.08.2022 | ASO Author Reflections
ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data
verfasst von:
Mark B. Ulanja, MD, MPH, Bryce D. Beutler, MD, Daniel Antwi-Amoabeng, MD, MSc, Samuel B. Governor, MD, MPH, Ganiyu A. Rahman, MBBS, FWACS, Francis Tanam Djankpa, BSc, MPhil, PhD, Olatunji B. Alese, MD, FWACS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 13/2022
Einloggen, um Zugang zu erhalten
Excerpt
Gastrointestinal extrapulmonary small cell carcinoma (GI EPSCCa) is a rare subtype of high-grade neuroendocrine cancer with increasing incidence in the US.
1 There is a paucity of data regarding the pattern of distribution, role of molecular aberrations, prognosis, and appropriate modalities of treatment in the management of this highly aggressive clinical entity. Limited available retrospective population-based studies are inconsistent on the role of surgical resection, chemotherapy, and radiation therapy (RT), including corresponding survival benefits. Guidelines for therapy are largely rudimentary.
2,3 Given its rarity, randomized trials are very limited and retrospective studies continue to inform therapy. …